Results 121 to 130 of about 44,419 (235)
Metachronous Primary Pancreatic Neuroendocrine Tumor and Adenocarcinoma: A Case Report
ABSTRACT Background Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis, with most patients presenting with advanced disease. Surgical resection remains the only potentially curative option, yet recurrence rates are high. Case We present a rare case of metachronous primary pancreatic neuroendocrine tumor (PanNET) and PDAC in a 71‐year‐old ...
Anastasia S. Fatyanova +7 more
wiley +1 more source
Detecting BRCA2 protein truncation in breast tissue biopsies to identify hereditary cancer.
Abstract #501 Background: Mutations in the BRCA2 gene are dominantly inherited but cause cancers when the wildtype allele has LOH (loss of heterozygosity) within the cancer.
V Clark +4 more
core +1 more source
grantor: University of TorontoMutations in the BRCA2 gene predispose women to familial, early onset breast cancer. BRCA2 has been implicated in DNA double-strand break repair through its interaction with hRad51, which is known to be involved in
Ionescu, Daniela
core +1 more source
Expression of BRCA1 and BRCA2 proteins and their correlation with clinical staging in breast cancer
The purpose of this study was to evaluate the level of expression of the BRCA1 and BRCA2 proteins in sporadic breast cancer cases to determine the functional role of these genes in breast carcinogenesis.Paraffin embedded histologically proven invasive breast tissue sections that were obtained from 40 patients and the adjacent normal breast tissue ...
Suresh, Hedau +5 more
openaire +2 more sources
ABSTRACT Introduction Systemic cervical cancer management continues to be challenging. Numerous chemotherapies have been approved, but predicting response is difficult due to the lack of biomarkers. Here, we analyze the genetic and protein profiles of 20 cervical cancer cell lines (CCCLs) and explore their correlation with drug response patterns to ...
Suzy Scholl +10 more
wiley +1 more source
Knockdown of the HR protein BRCA2 sensitizes glioma cells to O6AA chemotherapeutics.
(A) BRCA2 protein expression following knockdown was assessed by western blot. (B) Clonogenic survival following TMZ treatments in transient BRCA2 or non-sense (n.s.) siRNA transfected glioma cells.
Wynand Paul Roos (340507) +2 more
core +1 more source
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk.
Common genetic variants contribute to the observed variation in breast cancer risk for BRCA2 mutation carriers; those known to date have all been found through population-based genome-wide association studies (GWAS).
Mia M Gaudet +131 more
doaj +1 more source
1. Lactate‐derived histone lactylation links glycolytic reprogramming to epigenetic regulation in female reproductive diseases. 2. In endometriosis, lactylation may promote inflammatory remodelling, immune dysregulation and ferroptosis resistance. 3. In PCOS, lactylation connects metabolic disturbance to granulosa‐cell dysfunction and hyperandrogenism.
Jiajun Qiao +5 more
wiley +1 more source
In silico analysis of the wild-type and mutant-type of BRCA2 gene
Background The aim of this study was to conduct an in silico analysis of a novel compound heterozygous variant in breast cancer susceptibility gene 2 (BRCA2) to clarify its structure–function relationship and elucidate the molecular mechanisms underlying
Jingjing Li +13 more
doaj +1 more source
Simultaneous treatment with lutein and cisplatin enhances oxidative DNA damage in breast cancer cells (MCF‐7 and MDA‐MB‐231) and promotes apoptosis specifically in MDA‐MB‐231 cells, while modulating DNA repair and damage response genes across cell types. Additionally, the combination increases cytotoxicity in HUVECs.
Funda Demirtas Korkmaz +2 more
wiley +1 more source

